For the Inventor, By the Inventor

Enter assignee name

Yongin-si, South Korea

Mogam Institute for Biomedical Research

USPTO Granted Patents = 16

CIPO Patents = 27

EPO Patents = 4

Forward Citations = 8

Loading Chart...

Loading Chart...

117 inventors (with patents filed for the assignee):

Eun Jung Song (5 out of 5 patents)

Mijung Lee (4 out of 6 patents)

Dong-Sik Kim (4 out of 5 patents)

4. Hyung-Kwon Lim (4 out of 7 patents)

5. Jong Wha Won (3 out of 3 patents)

6. Jongwha Won (3 out of 3 patents)

7. Hyo Jung Nam (3 out of 4 patents)

8. Kisu Kim (3 out of 3 patents)

9. Ki Su Kim (3 out of 3 patents)

10. Young Seoub Park (3 out of 4 patents)

11. Kyuhyun Lee (2 out of 10 patents)

12. Hyung Kwon Lim (2 out of 2 patents)

13. Miyoung Oh (2 out of 2 patents)

14. Sujeong Kim (2 out of 15 patents)

15. Soongyu Choi (2 out of 12 patents)

16 patents: Sort by Forward Citations

1. 12319746 - Bispecific antibody specifically binding to GPNMB and CD3, and use thereof (2025-06-03),

2. 12098209 - Fusion protein comprising IDS and use thereof (2024-09-24),

3. 12071710 - Antibody library and antibody screening method using same (2024-08-27),

4. 11766456 - Method for culturing natural killer cells using T cells (2023-09-26),

5. 11642408 - Antigen variant of Varicella Zoster virus and use thereof (2023-05-09),

6. 11498965 - Anti-CD3 antibody and pharmaceutical composition for cancer treatment comprising same (2022-11-15),

7. 11447559 - Anti-BCMA antibody having high affinity for BCMA and pharmaceutical composition for treatment of cancer, comprising same (2022-09-20),

8. 11401343 - Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same (2022-08-02),

9. 11332528 - Anti-CEACAM1 antibody and use thereof (2022-05-17),

10. 11198733 - Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient, antibody that specifically binds to epidermal growth factor receptor (2021-12-14),

11. 11046749 - Chimera protein comprising FVIII and vWF factors, and use thereof (2021-06-29),

12. 10940198 - Herpes zoster vaccine composition (2021-03-09),

13. 10874734 - Varicella zoster virus vaccine (2020-12-29),

14. 10851175 - Anti-mesothelin antibody and composition comprising the same (2020-12-01),

15. 10752697 - Anti-glypican 3 antibody and pharmaceutical composition containing the same (2020-08-25),

MOGAM Institute for Biomedical Research is a leading institution dedicated to advancing biomedical research and development. With state-of-the-art facilities and a team of highly skilled scientists, we strive to provide innovative solutions for improving human health. Our research focuses on various areas including genetics, molecular biology, drug discovery, and diagnostics. We collaborate with renowned academic institutions and pharmaceutical companies to accelerate the translation of scientific discoveries into medical breakthroughs. Visit our website to learn more about our research projects, publications, and ongoing collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

16 Patents

#16 in Yongin-si

#706 in South Korea

#36,617 in the World

Yongin-si, South Korea

Mogam Institute for Biomedical Research

Forward Citations = 8

117 inventors:

Eun Jung Song (5 out of 5 patents)

Mijung Lee (4 out of 6 patents)

Dong-Sik Kim (4 out of 5 patents)

4. Hyung-Kwon Lim (4 out of 7 patents)

5. Jong Wha Won (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…